- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
The Day-to-Day Effect of a Schizophrenia Diagnosis on Patient Quality of Life
Patients with schizophrenia have a lot of life-changing consequences when they are being treated properly, and these are only amplified when the patient goes untreated, explained Megan Ehret, PharmD, of University of Maryland, School of Pharmacy.
There are life-changing aspects to schizophrenia that are amplified when patients are untreated for the condition, explained Megan Ehret, PharmD, MS, BCPP, professor and codirector of the Mental Health Program, University of Maryland, School of Pharmacy.
Ehret discussed schizophrenia management strategies in a session at AMCP Nexus, held October 14-17 in Las Vegas, Nevada.
This transcript has been lightly edited for clarity.
Transcript
How does a schizophrenia diagnosis affect the day-to-day lives of patients both when they are being treated properly and when they are not?
When we think about the treatment of schizophrenia, there are life-changing consequences just to the illness itself. There is a lot more social isolation. There can be stigma and reduced aspects and quality of life. You may be less likely to have a partner, less likely to maybe accomplish college or other aspects of life.
When it goes untreated, those are just amplified. The patient may be hearing voices. They may be paranoid about things around them. Ultimately, each of those things can affect different parts of their lives. They also, additionally, have the potential with schizophrenia to have a reduced life expectancy because of some of the aspects of the illness.
When schizophrenia is appropriately treated, and we use an effective medication, people can go on to have the same quality of life as someone without schizophrenia. They are able to attend college, able to obtain employment, able to have families and function. I think Bethany's story [from the AMCP Nexus session] really highlights how when she found the most effective treatment, she was able to continue on and finish her college degree and complete the quality of life that she was looking for.
It's unfortunate many of our treatments also decrease the life expectancy, because of the adverse effects that can occur from those. So, it's important that when patients are engaged in treatment that they continue to have monitoring so that we can make sure that those things are all adequately monitored and watched for.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
